Generating Effective and Novel Evidence for Therapy Payment Act or the GENE Therapy Payment Act
This bill allows state Medicaid programs to pay for certain gene therapy drugs through risk-sharing value-based payment agreements with drug manufacturers. The bill applies to covered outpatient drugs that provide potentially curative treatment for serious or life-threatening rare diseases or conditions after not more than three administrations.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2020-02-12 | IntroReferral | Referred to the House Committee on Energy and Commerce. | House floor actions |
| 2020-02-12 | IntroReferral | Introduced in House | Library of Congress |